FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
News|Articles|November 19, 2021
COVID-19 Updates: US Vaccinations, Booster Doses, & Global Data as of November 19, 2021
Author(s)Sydney Jennings
Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.
Advertisement
How many fully vaccinated Americans have received a booster dose?
According to the
How many people in the US have been vaccinated against COVID-19?
According to the CDC as of today, November 12, 2021, at 3:25 PM, EDT:
• 68.8% of total US population has received at least 1 dose
• 58.9% of total US population is fully vaccinated
• 58.9% of total US population is fully vaccinated
The 5 states/territories with the highest percentage of population fully vaccinated are:
1. Puerto Rico: 74.3%
2. Vermont: 72.2%
3. Rhode Island:71.9%
4. Maine: 71.7%
5. Connecticut: 71.5%
2. Vermont: 72.2%
3. Rhode Island:71.9%
4. Maine: 71.7%
5. Connecticut: 71.5%
How many cases of COVID-19 have been confirmed in the US?
According to the Johns Hopkins COVID-19 interactive map , as of today, November 19, 2021 at 2:22 PM, EDT, there have been:
• 47 582 349 confirmed cases and
• 769 484 deaths
• 769 484 deaths
The 5 states with the highest total confirmed cases are:
1. California: 5 033 302
2. Texas: 4 303 916
3. Florida: 3 711 612
4. New York: 2 653 527
5. Illinois: 1 763 858
2. Texas: 4 303 916
3. Florida: 3 711 612
4. New York: 2 653 527
5. Illinois: 1 763 858
Deaths: California has the highest number of deaths due to COVID-19 with 73 660 reported fatalities, followed by Texas with 73 276 and Florida with 60 846.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 256 474 049 confirmed cases, 5 137 828 deaths, and 7 616 499 951 vaccine doses administered.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
2
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
3
Multicomponent Strategies to Ease Vaccination Pain and Fear Across Ages
4
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
5